NEW YORK (GenomeWeb) – Ag-bio firm DuPont Pioneer announced today that it has acquired an exclusive license to guided Cas9 genome-editing technology from Vilnius University for all commercial uses, including agricultural ones.

Under the deal, DuPont Pioneer and the university will also collaborate on the technology's development. Financial terms of the arrangement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.